Revenues of WEST PHARMACEUTICAL SERVICES INC from 31 Dec 2016 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: WEST PHARMACEUTICAL SERVICES INC quarterly and annual Revenues in USD history and change rate from 31 Dec 2016 to 31 Mar 2024.
WEST PHARMACEUTICAL SERVICES INC Revenues for the quarter ending 31 Mar 2024 was $695,400,000, a 3% decline year-over-year.
WEST PHARMACEUTICAL SERVICES INC annual Revenues for 2022 was $2,886,900,000, a 2% increase from 2021.
WEST PHARMACEUTICAL SERVICES INC annual Revenues for 2021 was $2,831,600,000, a 32% increase from 2020.
WEST PHARMACEUTICAL SERVICES INC annual Revenues for 2020 was $2,146,900,000, a 17% increase from 2019.
Source SEC data: View on sec.gov

Revenues, Trailing 12 Months (USD)

Revenues, Quarterly (USD)

Revenues, YoY Quarterly Change (%)

Revenues, Annual (USD)

Revenues, YoY Annual Change (%)

WEST PHARMACEUTICAL SERVICES INC Quarterly Revenues (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024		$695,400,000	-$21,200,000	-3%	01 Jan 2024	31 Mar 2024	10-Q	25 Apr 2024	2024	Q1
Q1 2023		$716,600,000	-$3,400,000	-0.47%	01 Jan 2023	31 Mar 2023	10-Q	25 Apr 2024	2024	Q1
Q1 2022		$720,000,000	+$49,300,000	+7.4%	01 Jan 2022	31 Mar 2022	10-Q	27 Apr 2023	2023	Q1
Q1 2021		$670,700,000	+$179,200,000	+36%	01 Jan 2021	31 Mar 2021	10-Q	28 Apr 2022	2022	Q1
Q1 2020	$1,887,900,000	$491,500,000	+$48,000,000	+11%	01 Jan 2020	31 Mar 2020	10-Q	30 Apr 2021	2021	Q1
Q4 2019	$1,839,900,000	$470,600,000	+$48,100,000	+11%	01 Oct 2019	31 Dec 2019	10-K	22 Feb 2022	2021	FY
Q3 2019	$1,791,800,000	$456,100,000	+$24,400,000	+5.7%	01 Jul 2019	30 Sep 2019	10-Q	29 Oct 2019	2019	Q3
Q2 2019	$1,767,400,000	$469,700,000	+$22,200,000	+5%	01 Apr 2019	30 Jun 2019	10-Q	29 Jul 2019	2019	Q2
Q1 2019	$1,745,200,000	$443,500,000	+$27,800,000	+6.7%	01 Jan 2019	31 Mar 2019	10-Q	24 Apr 2020	2020	Q1
Q4 2018	$1,717,400,000	$422,500,000			01 Oct 2018	31 Dec 2018	10-K	23 Feb 2021	2020	FY
Q3 2018		$431,700,000	+$33,500,000	+8.4%	01 Jul 2018	30 Sep 2018	10-Q	29 Oct 2019	2019	Q3
Q2 2018		$447,500,000			01 Apr 2018	30 Jun 2018	10-Q	29 Jul 2019	2019	Q2
Q1 2018		$415,700,000			01 Jan 2018	31 Mar 2018	10-Q	08 May 2019	2019	Q1
Q3 2017		$398,200,000			01 Jul 2017	30 Sep 2017	10-Q	30 Oct 2018	2018	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2022	$2,886,900,000	+$55,300,000	+2%	01 Jan 2022	31 Dec 2022	10-K	21 Feb 2023	2022	FY
2021	$2,831,600,000	+$684,700,000	+32%	01 Jan 2021	31 Dec 2021	10-K	21 Feb 2023	2022	FY
2020	$2,146,900,000	+$307,000,000	+17%	01 Jan 2020	31 Dec 2020	10-K	21 Feb 2023	2022	FY
2019	$1,839,900,000	+$122,500,000	+7.1%	01 Jan 2019	31 Dec 2019	10-K	22 Feb 2022	2021	FY
2018	$1,717,400,000	+$118,300,000	+7.4%	01 Jan 2018	31 Dec 2018	10-K	23 Feb 2021	2020	FY
2017	$1,599,100,000	+$90,000,000	+6%	01 Jan 2017	31 Dec 2017	10-K	24 Feb 2020	2019	FY
2016	$1,509,100,000			01 Jan 2016	31 Dec 2016	10-K	28 Feb 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.